Literature DB >> 4088694

Cephalad migration of morphine in CSF following lumbar epidural administration in patients with cancer pain.

G K Gourlay, D A Cherry, M J Cousins.   

Abstract

This study examines the cephalad migration of morphine in CSF following lumbar epidural administration in cancer patients with pain. Fourteen cancer patients were administered 10 mg of morphine in 10 ml of normal saline via an epidural catheter inserted in the lumbar region (usually L2.3) and attached to a subcutaneously implanted portal for drug administration. There was a rapid vascular uptake of morphine from the epidural space with a mean (+/- S.D.) peak blood concentration of 110 +/- 32 ng/ml (range 76-182 ng/ml and the mean time associated with this peak blood concentration was 5.1 +/- 2.3 min (range 2-10 min). A cervical CSF sample was obtained from the C7-T1 interspace in each patient at one of the following times from the completion of the epidural morphine dose: 10, 30, 60, 120, 180, 240 or 360 min. There was a delay of at least 60 min before morphine was detected in significant concentrations (approximately 300 ng/ml) in the cervical CSF samples and peak CSF concentrations occurred after approximately 3 h. The results of this study are compatable with the hypothesis that the delayed onset of respiratory depression sometimes observed following epidural morphine in opioid naive patients results from significant amounts of morphine reaching the respiratory centre in the brain-stem as a consequence of passive CSF flow in a rostral direction from the lumbar region.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4088694     DOI: 10.1016/0304-3959(85)90001-6

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  11 in total

1.  Side effects during continuous epidural infusion of morphine and fentanyl.

Authors:  M J White; E J Berghausen; S W Dumont; K Tsueda; J A Schroeder; R L Vogel; M F Heine; K C Huang
Journal:  Can J Anaesth       Date:  1992-07       Impact factor: 5.063

2.  [The estimation of the i.m. morphine-equivalent in cancer pain treatment with different opioids or different routes of administrations. Practical meaning and limitations.].

Authors:  J Jage; R K Portenoy; K M Foley
Journal:  Schmerz       Date:  1990-06       Impact factor: 1.107

Review 3.  Neuraxial morphine and respiratory depression: finding the right balance.

Authors:  Pervez Sultan; Maria Cristina Gutierrez; Brendan Carvalho
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

Review 4.  Intraspinal opioids: implications for monitoring. Monitoring in the intensive care unit is essential.

Authors:  R F LaPorta; M D Johnson
Journal:  J Clin Monit       Date:  1989-07

5.  Pharmacokinetics of different epidural sites of morphine administration.

Authors:  G Nordberg; V Hansdottir; L Kvist; T Mellstrand; T Hedner
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Complications of spinal opioid therapy: myoclonus, spastic muscle tone and spinal jerking.

Authors:  M Kloke; U Bingel; S Seeber
Journal:  Support Care Cancer       Date:  1994-07       Impact factor: 3.603

Review 7.  Side effects of intrathecal and epidural opioids.

Authors:  M A Chaney
Journal:  Can J Anaesth       Date:  1995-10       Impact factor: 5.063

Review 8.  Respiratory depression and spinal opioids.

Authors:  R C Etches; A N Sandler; M D Daley
Journal:  Can J Anaesth       Date:  1989-03       Impact factor: 5.063

9.  Reversal of epidural morphine-induced respiratory depression and pruritus with nalbuphine.

Authors:  J P Penning; B Samson; A D Baxter
Journal:  Can J Anaesth       Date:  1988-11       Impact factor: 5.063

10.  [The clinical use of spinal opioids, part 2].

Authors:  N Rawal
Journal:  Schmerz       Date:  1996-10-28       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.